×

The impact of known breast cancer polygenes on critical illness insurance. (English) Zbl 1398.91304

Summary: General studies indicate that the inherited risk of breast cancer is mediated by the well-studied major genes BRCA1 and BRCA2, and a polygenic component, probably with many genes each making a small contribution. Recently, seven polygenes have been found contributing an estimated \(3.6\%\) of all familial risk. This suggests that the polygenic component may involve well over 100 genetic loci. We extrapolate these new results into a polygenic model with 147 genetic loci and simulate lifetimes of families to calculate the premium ratings appropriate for a family history of breast or ovarian cancer. We model the adverse selection costs arising from restricting the use of genetic test information in critical illness insurance underwriting in light of new European legislation banning the use of gender for insurance underwriting. In this setting, we confirm the overall conclusion of a previous study which used a simpler model that the polygene confers higher adverse selection risk than the BRCA genes. We establish that their three-gene polygenic model does not overly inflate the insurance costs attributable to a polygenic component of breast cancer risk under a model with 147 polygenes.

MSC:

91B30 Risk theory, insurance (MSC2010)
62P05 Applications of statistics to actuarial sciences and financial mathematics
62P10 Applications of statistics to biology and medical sciences; meta analysis
92D10 Genetics and epigenetics
PDFBibTeX XMLCite
Full Text: DOI

References:

[1] Antoniou, A., Pharoah, P., McMullan, G., Day, N., Ponder, B. & Easton, D. (2001). Evidence for further breast caner susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genetic Epidemiology 21, 1-18.
[2] Antoniou, A., Pharoah, P., McMullan, G., Day, N., Stratton, M., Peto, J., Ponder, B. & Easton, D. (2002). A comprehensive model for familial BC incorporating BRCA1, BRCA2 and other genes. British Journal of Cancer 86, 76-83.
[3] Antoniou, A. C., Spurdle, A. B., Sinilnikova, O. M., Healey, S., Pooley, K. A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., Hofmann, W., Sutter, C., Niederacher, D., Deissler, H., Caldes, T., Kampjarvi, K., Nevanlinna, H., Simard, J., Beesley, J., Chen, X., Neuhausen, S. L., Rebbeck, T. R., Wagner, T., Lynch, H. T., Isaacs, C., Weitzel, J., Ganz, P. A., Daly, M. B., Tomlinson, G., Olopade, O. I., Bium, J. L., Couch, F. J., Peterlongo, P., Manoukian, S., Barile, M., Radice, P., Szabo, C. I., Pereira, L. H. M., Greene, M. H., Rennert, G., Leibkowicz, F., Barnett-Griness, O., Andrulis, I. L., Ozcelik, H., Gerdes, A. M., Caligo, M. A., Laitman, Y., Kaufman, B., Milgrom, R., Friedman, E., Domchek, S. M., Nathanson, K. L., Osorio, A., Llort, G., Milne, R. L., Benitez, J., Hamann, U., Hogervorst, F. B. L., Manders, P., Ligtenberg, M. J. L., van den Ouweland, A. M. W., Peock, S., Cook, M., Platte, R., Evans, D. G., Eeles, R., Pichert, G., Chu, C., Eccles, D., Davidson, R., Douglas, F., Godwin, A. K., Barjhoux, L., Mazoyer, S., Sobol, H., Bourdon, V., Eisinger, F., Chompret, A., Capoulade, C. & Paillerets, B. B. D., Lenoir, G. M., Gauthier-Villars, M., Houdayer, C., Stoppa-Lyonnet, D., Easton, D. F., Res, K. C. C., OCGN, Swedish BRCA1 and DNA-HEBON Collaborators, EMBRACE, GEMO & CIMBA. (2008). Common breast cancer-predisposition alleles are associated with BC risk in BRCA1 and BRCA2 mutation carriers. American Journal of Human Genetics82, 937-948.
[4] Brown, M. (1992). Evidence of adverse selection in the individual health insurance market. The Journal of Risk and Insurance 59, 13-33.
[5] Cox, A., Dunning, A. M., Garcia-Closas, M., Balasubramanian, S., Reed, M. W., Pooley, K. A., Scollen, S., Baynes, C., Ponder, B. A., Chanock, S., Lissowska, J., Brinton, L., Peplonska, B., Southey, M. C., Hopper, J. L., McCredie, M. R., Giles, G. G., Fletcher, O., Johnson, N., dos Santos Silva, I., Gibson, L., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Torres, D., Hamann, U., Justenhoven, C., Brauch, H., Chang-Claude, J., Kropp, S., Risch, A., Wang-Gohrke, S., Schuermann, P., Bogdanova, N., Doerk, T., Fagerholm, R., Aaltonen, K., Blomqvist, C., Nevanlinna, H., Seal, S., Renwick, A., Stratton, M. R., Rahman, N., Sangrajrang, S., Hughes, D., Odefrey, F., Brennan, P., Spurdle, A. B., Chenevix-Trench, G., Beesley, J., Mannermaa, A., Har- tikainen, J., Kataja, V., Kosma, V. M., Couch, F. J., Olson, J. E., Goode, E. L., Broeks, A., Schmidt, M. K., Hogervorst, F. B. L., Van’t Veer, L. J., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Wedren, S., Hall, P., Low, Y. L., Liu, J., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Sigurdson, A. J., Stredrick, D. L., Alexander, B. H., Struewing, J. P., Pharoah, P. D., Easton, D. F., Kathleen Cunningham Fdn Consortium & Breast Canc Assoc Consortium. (2007). A common coding variant in CASP8 is associated with BC risk. Nature Genetics39(3), 352-358.
[6] Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., Wareham, N., Ahmed, S., Healey, C. S., Bow- man, R., Meyer, K. B., Haiman, C. A., Kolonel, L. K., Henderson, B. E., Le Marchand, L., Brennan, P., Sangrajrang, S., Gaborieau, V., Odefrey, F., Shen, C. Y., Wu, P. E., Wang, H. C., Eccles, D., Evans, D. G., Peto, J., Fletcher, O., Johnson, N., Seal, S., Stratton, M. R., Rahman, N., Chenevix- Trench, G., Bojesen, S. E., Nordestgaard, B. G., Axelsson, C. K., Garcia-Closas, M., Brinton, L., Chanock, S., Lissowska, J., Peplonska, B., Nevanlinna, H., Fagerholm, R., Eerola, H., Kang, D., Yoo, K. Y., Noh, D. Y., Ahn, S. H., Hunter, D. J., Hankinson, S. E., Cox, D. G., Hall, P., Wedren, S., Liu, J., Low, Y. L., Bogdanova, N., Schuermann, P., Doerk, T., Tollenaar, R. A. E. M., Jacobi, C. E., Devilee, P., Klijn, J. G. M., Sigurdson, A. J., Doody, M. M., Alexander, B. H., Zhang, J., Cox, A., Brock, I. W., MacPherson, G., Reed, M. W. R., Couch, F. J., Goode, E. L., Olson, J. E., Meijers- Heijboer, H., van den Ouweland, A., Uitterlinden, A., Rivadeneira, F., Milne, R. L., Ribas, G., Gonzalez-Neira, A., Benitez, J., Hopper, J. L., McCredie, M., Southey, M., Giles, G. G., Schroen, C., Justenhoven, C., Brauch, H., Hamann, U., Ko, Y. D., Spurdle, A. B., Beesley, J., Chen, X., Mannermaa, A., Kosma, V. M., Kataja, V., Hartikainen, J., Day, N. E., Cox, D. R., Ponder, B. A. J., SEARCH Collaborators, kConFab & AOCS Management Grp. (2007). Genome-wide association study identifies novel BC susceptibility loci. Nature447, 1087-1095.
[7] European Court of Justice. (2011). C-236/09 Association Belge des Consommateurs Test-Achats ASBL. ECR I-00773.
[8] Finkelstein, A. & McGarry, K. (2006). Multiple dimensions of private information: evidence from the long- term care insurance market. American Economics Review 96, 938-958.
[9] Finkelstein, A. & Poterba, J. (2002). Selection efects in the United Kingdom individual annuities market. The Economic Journal 112(476), 28-50.
[10] Ghoussaini, M., Fletcher, O., Michailidou, K., Turnbull, C., Schmidt, M. K., Dicks, E., Dennis, J., Wang, Q., Humphreys, M. K., Luccarini, C., Baynes, C., Conroy, D., Maranian, M., Ahmed, S., Driver, K., Johnson, N., Orr, N., dos Santos Silva, I., Waisfisz, Q., Meijers-Heijboer, H., Uitterlinden, A. G., Rivadeneira, F., Hall, P., Czene, K., Irwanto, A., Liu, J., Nevanlinna, H., Aittomaki, K., Blomqvist, C., Meindl, A., Schmutzler, R. K., Muller-Myhsok, B., Lichtner, P., Chang-Claude, J., Hein, R., Nickels, S., Flesch-Janys, D., Tsimiklis, H., Makalic, E., Schmidt, D., Bui, M., Hopper, J. L., Apicella, C., Park, D. J., Southey, M., Hunter, D. J., Chanock, S. J., Broeks, A., Verhoef, S., Hogervorst, F. B., Fasching, P. A., Lux, M. P., Beckmann, M. W., Ekici, A. B., Sawyer, E., Tomlinson, I., Kerin, M., Marme, F., Schneeweiss, A., Sohn, C., Burwinkel, B., Guenel, P., Truong, T., Cordina-Duverger, E., Menegaux, F., Bojesen, S. E., Nordestgaard, B. G., Nielsen, S. F., Flyger, H., Milne, R. L., Alonso, M. R., Gonzalez-Neira, A., Benitez, J., Anton- Culver, H., Ziogas, A., Bernstein, L., Dur, C. C., Brenner, H., Muller, H., Arndt, V., Stegmaier, C., Justenhoven, C., Brauch, H., Bruning, T., Wang-Gohrke, S., Eilber, U., Dork, T., Schurmann, P., Bremer, M., Hillemanns, P., Bogdanova, N. V., Antonenkova, N. N., Rogov, Y. I., Karstens, J. H., Bermisheva, M., Prokofieva, D., Khusnutdinova, E., Lindblom, A., Margolin, S., Manner- maa, A., Kataja, V., Kosma, V. M., Hartikainen, J. M., Lambrechts, D., Yesilyurt, B. T., Floris, G., Leunen, K., Manoukian, S., Bonanni, B., Fortuzzi, S., Peterlongo, P., Couch, F. J., Wang, X., Stevens, K., Lee, A., Giles, G. G., Baglietto, L., Severi, G., McLean, C., Alnaes, G. G., Kristensen, V., Borrensen-Dale, A. L., John, E. M., Miron, A., Winqvist, R., Pylkas, K., Jukkola-Vuorinen, A., Kauppila, S., Andrulis, I. L., Glendon, G., Mulligan, A. M., Devilee, P., van Asperen, C. J., Tollenaar, R. A., Seynaeve, C., Figueroa, J. D., Garcia-Closas, M., Brinton, L., Lissowska, J., Hooning, M. J., Hollestelle, A., Oldenburg, R. A., van den Ouweland, A. M., Cox, A., Reed, M. W., Shah, M., Jakubowska, A., Lubinski, J., Jaworska, K., Durda, K., Jones, M., Schoemaker, M., Ashworth, A., Swerdlow, A., Beesley, J., Chen, X., Muir, K. R., Lophatananon, A., Rattana- mongkongul, S., Chaiwerawattana, A., Kang, D., Yoo, K. Y., Noh, D. Y., Shen, C. Y., Yu, J. C., Wu, P. E., Hsiung, C. N., Perkins, A., Swann, R., Velentzis, L., Eccles, D. M., Tapper, W. J., Gerty, S. M., Graham, N. J., Ponder, B. A., Chenevix-Trench, G., Pharoah, P. D., Lathrop, M., Dunning, A. M., Rahman, N., Peto, J. & Easton, D. (2012). Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genetics44(3), 312-318.
[11] Gui, E. H., Lu, B., Macdonald, A. S., Waters, H. R. & Wekwete, C. T. (2006). The genetics of breast and ovarian cancer III: a new model of family history with insurance applications. Scandinavian Actuarial Journal 6, 413-419. · Zbl 1129.91332
[12] Gutierrez, C. & Macdonald, A. S. (2003). Adult polycystic kidney disease and critical illness insurance. North American Actuarial Journal 7(2), 93-115. · Zbl 1084.62531
[13] Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., Wang, J., Yu, K., Chatterjee, N., Orr, N., Willett, W. C., Colditz, G. A., Ziegler, R. G., Berg, C. D., Buys, S. S., McCarty, C. A., Feigelson, H. S., Calle, E. E., Thun, M. J., Hayes, R. B., Tucker, M., Gerhard, D. S., Hoover, R. N., Thomas, G. & Chanock, S. J. (2007). A genome-wide association study identifies alleles in fgfr2 associated with risk of sporadic postmenopausal breast cancer. Nature Genetics 39, 870-874.
[14] Lange, K. (1997). An approximate model of polygenic inheritance. Genetics 147, 1423-1430.
[15] Lemaire, J., Subramanian, K., Armstrong, K. & Asch, D. (2000). Pricing term insurance in the presence of a family history of breast or ovarian cancer. North American Actuarial Journal 4, 75-87. · Zbl 1083.62536
[16] Lu, B., Macdonald, A. S. & Waters, H. R. (2011). The genetics of breast and ovarian cancer IV: a model of breast cancer progression. Scandinavian Actuarial Journal 6, 239-266. · Zbl 1277.92015
[17] Lu, B., Macdonald, A. S., Waters, H. R. & Yu, F. (2011). The genetics of breast and ovarian cancer V: application to income protection insurance. Scandinavian Actuarial Journal 4, 267-291. · Zbl 1277.92016
[18] Macdonald, A. S. & McIvor, K. (2006). Application of a polygenic model of breast and ovarian cancer to critical illness insurance. Annals of Actuarial Science 1(2), 319-343.
[19] Macdonald, A. S. & McIvor, K. (2009). Modelling adverse selection in the presence of a common genetic disorder: the breast cancer polygene. ASTIN Bulletin 39, 373-402.
[20] Macdonald, A. S., Waters, H. R. & Wekwete, C. T. (2003a). The genetics of breast and ovarian cancer I: a model of family history. Scandinavian Actuarial Journal2003, 1-27. · Zbl 1087.92041
[21] Macdonald, A. S., Waters, H. R. & Wekwete, C. T. (2003b). The genetics of breast and ovarian cancer II: a model of critical illness insurance. Scandinavian Actuarial Journal2003, 28-50. · Zbl 1087.92042
[22] Narod, S., Neuhausen, S., Vichodez, G., Armel, S., Lynch, H., Ghadirian, P., Cummings, S., Olopade, O., Stoppa-Lyonnet, D., Couch, F., Wagner, T., Warner, E., Foulkes, W., Saal, H., Weitzel, J., Tulman, A., Poll, A., Nam, R., Sun, P. & Hereditary Breast Cancer Study Grp. (2008). Rapid progression of prostate cancer in men with a BRCA2 mutation. British Journal of Cancer99(2), 371-374.
[23] Parkin, D., Bray, F. & Devesa, S. (2001). Cancer burden in the year 2000, the global picture. European Journal of Cancer 37(Suppl. 8), 4-66.
[24] Pharoah, P. D., Antoniou, A. C., Easton, D. F. & Ponder, B. A. (2008). Polygenes, risk prediction, and targeted prevention of breast cancer. New England Journal of Medicine 358, 2796-2803.
[25] Ropka, M., Wenzel, J., Phillips, E., Siadaty, M. & Philbrick, J. (2006). Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiology, Biomarkers, and Prevention 15(5), 840-855.
[26] Stacey, S. N., Manolescu, A., Sulem, P., Rafnar, T., Gudmundsson, J., Gudjonsson, S. A., Masson, G., Jakobsdottir, M., Thorlacius, S., Helgason, A., Aben, K. K., Strobbe, L. J., Albers-Akkers, M. T., Swinkels, D. W., Henderson, B. E., Kolonel, L. N., Le Marchand, L., Millastre, E., Andres, R., Godino, J., Garcia-Prats, M. D., Polo, E., Tres, A., Mouy, M., Saemundsdottir, J., Backman, V. M., Gudmundsson, L., Kristjansson, K., Bergthorsson, J. T., Kostic, J., Frigge, M. L., Geller, F., Gudbjartsson, D., Sigurdsson, H., Jonsdottir, T., Hrafnkelsson, J., Johannsson, J., Sveinsson, T., Myrdal, G., Grimsson, H. N., Jonsson, T., von Holst, S., Werelius, B., Margolin, S., Lindblom, A., Mayordomo, J. I., Haiman, C. A., Kiemeney, L. A., Johannsson, O. T., Gulcher, J. R., Thorsteins- dottir, U., Kong, A. & Stefansson, K. (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nature Genetics39(7), 865-869.
[27] Subramanian, K., Lemaire, J., Hershey, J., Pauly, M., Armstrong, K. & Asch, D. (1999). Estimating adverse selection costs from genetic testing for breast and ovarian cancer: the case of life insurance. Journal of Riks and Insurance 66(4), 531-550.
[28] Tai, Y. C., Domchek, S., Parmigiani, G. & Chen, S. (2007). Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute 99(23), 1811-1814.
[29] Tutt, A. & Ashworth, A. (2002). The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends in Molecular Medicine 8(12), 571-579.
[30] Washbrook, E. (2006). Risk factors and epidemiology of breast cancer. Womens Health Medicine 3(1), 8-14.
[31] Zick, C. D., Smith, K. R., Mayer, R. N. & Botkin, J. R. (2000). Genetic testing, adverse selection, and the demand for life insurance. American Journal of Medical Genetics 93(1), 29-39.
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.